<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The relative in vitro anti-oxidant efficacy of sulphasalazine (salicylazosulphapyridine, SASP) and its metabolites (<z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi>, <z:chebi fb="0" ids="6775">5-ASA</z:chebi>; <z:chebi fb="0" ids="132842">sulphapyridine</z:chebi>, SP) was examined by studying their effects on the generation of reactive oxygen species (ROS) using zymosan-stimulated polymorphonuclear leucocytes (PMNs) and a cell free, <z:chebi fb="1" ids="15318,17712">xanthine</z:chebi>-<z:chebi fb="1" ids="15318,17712">xanthine</z:chebi> oxidase system </plain></SENT>
<SENT sid="1" pm="."><plain>Salicylazosulphapyridine, <z:chebi fb="0" ids="6775">5-ASA</z:chebi>, and SP showed anti-oxidant effects to the various degrees </plain></SENT>
<SENT sid="2" pm="."><plain>In particular, production of OH, which is one of the most potent reactive oxygen species, was remarkably suppressed by <z:chebi fb="0" ids="6775">5-ASA</z:chebi> dose relatedly </plain></SENT>
<SENT sid="3" pm="."><plain>These findings suggest that SASP and its metabolites play an important role in the inhibition of respiratory bursts </plain></SENT>
<SENT sid="4" pm="."><plain>As the potent products of the respiratory burst by polymorphonuclear leucocytes are thought to be important <z:mp ids='MP_0002501'>inflammatory mediators</z:mp>, suppression of toxic reactive oxygen species generation by these agents may partly explain the therapeutic efficacy of SASP in <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, which is characterised by an <z:hpo ids='HP_0011009'>acute</z:hpo> mucosal <z:mp ids='MP_0001845'>inflammation</z:mp> dominated by polymorphonuclear leucocytes accumulation </plain></SENT>
</text></document>